Genomewide association study of severe Covid-19 with respiratory failure Severe Covid-19 GWAS Group New England Journal of Medicine 383 (16), 1522-1534, 2020 | 1945 | 2020 |
Mapping the human genetic architecture of COVID-19 Writing group Writing group leaders Pathak Gita A. 6 Andrews Shea J. 7 Kanai ... Nature 600 (7889), 472-477, 2021 | 752 | 2021 |
Rheumatoid factors: clinical applications F Ingegnoli, R Castelli, R Gualtierotti Disease markers 35 (6), 727-734, 2013 | 390 | 2013 |
Complement activation in patients with COVID-19: A novel therapeutic target M Cugno, PL Meroni, R Gualtierotti, S Griffini, E Grovetti, A Torri, ... Journal of Allergy and Clinical Immunology 146 (1), 215-217, 2020 | 268 | 2020 |
The ADAMTS13‐von Willebrand factor axis in COVID‐19 patients I Mancini, L Baronciani, A Artoni, P Colpani, M Biganzoli, G Cozzi, ... Journal of Thrombosis and Haemostasis 19 (2), 513-521, 2021 | 227 | 2021 |
Updating on the pathogenesis of systemic lupus erythematosus R Gualtierotti, M Biggioggero, AE Penatti, PL Meroni Autoimmunity reviews 10 (1), 3-7, 2010 | 225 | 2010 |
Prognostic model based on nailfold capillaroscopy for identifying Raynaud's phenomenon patients at high risk for the development of a scleroderma spectrum disorder: PRINCE … F Ingegnoli, P Boracchi, R Gualtierotti, C Lubatti, L Meani, L Zahalkova, ... Arthritis & Rheumatism: Official Journal of the American College of …, 2008 | 182 | 2008 |
Complement activation and endothelial perturbation parallel COVID-19 severity and activity M Cugno, PL Meroni, R Gualtierotti, S Griffini, E Grovetti, A Torri, P Lonati, ... Journal of autoimmunity 116, 102560, 2021 | 161 | 2021 |
Inflammatory mediators and signalling pathways controlling intervertebral disc degeneration SE Navone, G Marfia, A Giannoni, M Beretta, L Guarnaccia, R Gualtierotti, ... Histology and histopathology 32 (6), 523-542, 2017 | 158 | 2017 |
Hemophilic arthropathy: current knowledge and future perspectives R Gualtierotti, LP Solimeno, F Peyvandi Journal of Thrombosis and Haemostasis 19 (9), 2112-2121, 2021 | 152 | 2021 |
Nailfold capillary patterns in healthy subjects: a real issue in capillaroscopy F Ingegnoli, R Gualtierotti, C Lubatti, C Bertolazzi, M Gutierrez, P Boracchi, ... Microvascular Research 90, 90-95, 2013 | 129 | 2013 |
Improving outcome prediction of systemic sclerosis from isolated Raynaud’s phenomenon: role of autoantibodies and nail-fold capillaroscopy F Ingegnoli, P Boracchi, R Gualtierotti, EM Biganzoli, S Zeni, C Lubatti, ... Rheumatology 49 (4), 797-805, 2010 | 126 | 2010 |
Mesenchymal stem cells: potential for therapy and treatment of chronic non-healing skin wounds G Marfia, SE Navone, C Di Vito, N Ughi, S Tabano, M Miozzo, ... Organogenesis 11 (4), 183-206, 2015 | 123 | 2015 |
Anakinra combined with methylprednisolone in patients with severe COVID-19 pneumonia and hyperinflammation: An observational cohort study G Bozzi, D Mangioni, F Minoia, S Aliberti, G Grasselli, L Barbetta, ... Journal of Allergy and Clinical Immunology 147 (2), 561-566. e4, 2021 | 112 | 2021 |
The ABO blood group locus and a chromosome 3 gene cluster associate with SARS-CoV-2 respiratory failure in an Italian-Spanish genome-wide association … D Ellinghaus, F Degenhardt, L Bujanda, M Buti, A Albillos, P Invernizzi, ... MedRxiv, 2020.05. 31.20114991, 2020 | 109 | 2020 |
Complement functional tests for monitoring eculizumab treatment in patients with atypical hemolytic uremic syndrome M Cugno, R Gualtierotti, I Possenti, S Testa, F Tel, S Griffini, E Grovetti, ... Journal of Thrombosis and Haemostasis 12 (9), 1440-1448, 2014 | 109 | 2014 |
P2X7 receptor restrains pathogenic Tfh cell generation in systemic lupus erythematosus CE Faliti, R Gualtierotti, E Rottoli, M Gerosa, L Perruzza, A Romagnani, ... Journal of Experimental Medicine 216 (2), 317-336, 2019 | 103 | 2019 |
Feasibility of different capillaroscopic measures for identifying nailfold microvascular alterations F Ingegnoli, R Gualtierotti, C Lubatti, L Zahalkova, L Meani, P Boracchi, ... Seminars in arthritis and rheumatism 38 (4), 289-295, 2009 | 93 | 2009 |
Autoantibodies to coagulation factors: from pathophysiology to diagnosis and therapy M Cugno, R Gualtierotti, A Tedeschi, PL Meroni Autoimmunity Reviews 13 (1), 40-48, 2014 | 79 | 2014 |
Early phases of COVID-19 are characterized by a reduction in lymphocyte populations and the presence of atypical monocytes A Lombardi, E Trombetta, A Cattaneo, V Castelli, E Palomba, M Tirone, ... Frontiers in immunology 11, 560330, 2020 | 69 | 2020 |